OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Viral persistence, reactivation, and mechanisms of long COVID
Benjamin K. Chen, Boris Jülg, Sindhu Mohandas, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 139

Showing 26-50 of 139 citing articles:

Prevalence and risk factors for long COVID in China: a systematic review and meta-analysis of observational studies
Le-Yan Hu, A. Cai, Bo Li, et al.
Journal of Infection and Public Health (2025) Vol. 18, Iss. 3, pp. 102652-102652
Open Access

Cerebromicrovascular mechanisms contributing to long COVID: implications for neurocognitive health
Mónika Fekete, Andrea Ceglédi, Ágnes Szappanos, et al.
GeroScience (2025)
Open Access

Post COVID-19 and Long COVID Symptoms in Otorhinolaryngology—A Narrative Review
Orlando Guntinas‐Lichius, Thomas Bitter, Robert P. Takes, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 506-506
Open Access

Positionspapier zum Post-COVID-Syndrom
Elisabeth Schieffer, Denise Hilfiker‐Kleiner, Axel Schlitt, et al.
Deleted Journal (2025)
Closed Access

Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS
Annick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1086-1086
Open Access

Virus-Induced Pathogenic Antibodies: Lessons from Long COVID and Dengue Hemorrhage Fever
Der‐Shan Sun, Te-Sheng Lien, Hsin‐Hou Chang
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 1898-1898
Open Access

The Role of Memory T-Cell Mediated Immunity in Long-term COVID-19: Effects of Vaccination Status.
Saulesh Kurmangaliyeva, Akzhan M. Madenbayeva, Saltanat T. Urazayeva, et al.
PubMed (2025) Vol. 50, Iss. 2, pp. 61-68
Closed Access

Macrophage peroxisomes guide alveolar regeneration and limit SARS-CoV-2 tissue sequelae
Xiaoqin Wei, Wei Qian, Harish Narasimhan, et al.
Science (2025) Vol. 387, Iss. 6738
Closed Access

Adult Long Coronavirus Disease 2019
Ivette F. Emery, Clifford J. Rosen
Infectious Disease Clinics of North America (2025)
Closed Access

Paxlovid as a potential treatment for long COVID
Matthew W. McCarthy
Expert Opinion on Pharmacotherapy (2023) Vol. 24, Iss. 17, pp. 1839-1843
Closed Access | Times Cited: 12

The demographic, laboratory and genetic factors associated with long Covid-19 syndrome: a case–control study
Ensiye Torki, Fahimeh Hoseininasab, Marjan Moradi, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4

Severe pediatric COVID-19: a review from the clinical and immunopathophysiological perspectives
Yikan Sun, Can Wang, Peiquan Lin, et al.
World Journal of Pediatrics (2024) Vol. 20, Iss. 4, pp. 307-324
Open Access | Times Cited: 4

Presence of SARS‐CoV‐2 RNA in COVID‐19 survivors with post‐COVID symptoms 2 years after hospitalization: The VIPER study
César Fernández‐de‐las‐Peñas, Juan Torres‐Macho, María Ruiz‐Ruigómez, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 5
Open Access | Times Cited: 4

Unraveling the enigma of long COVID: novel aspects in pathogenesis, diagnosis, and treatment protocols
Abdul Mannan Baig, Sandy Rosko, B.R. Jaeger, et al.
Inflammopharmacology (2024) Vol. 32, Iss. 4, pp. 2075-2090
Closed Access | Times Cited: 4

Review of organ damage from COVID and Long COVID: a disease with a spectrum of pathology
Andrew G. Ewing, Špela Šalamon, Etheresia Pretorius, et al.
Medical Review (2024) Vol. 5, Iss. 1, pp. 66-75
Open Access | Times Cited: 4

SARS-CoV-2 papain-like protease activates nociceptors to drive sneeze and pain
Sonali S. Mali, Ricardo Silva, Zhongyan Gong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

UB-612 pan-SARS-CoV-2 T cell immunity-promoting vaccine protects against COVID-19 moderate-severe disease
Chang Yi Wang, Be-Sheng Kuo, Yu-Hsiang Lee, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108887-108887
Open Access | Times Cited: 3

Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 3

Tracking inflammation resolution signatures in lungs after SARS-CoV-2 omicron BA.1 infection of K18-hACE2 mice
Agnes Carolin, Kexin Yan, Cameron Bishop, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Framing Long Covid through Patient activism in the United States: Patient, Provider, Academic, and Policymaker Views
Kenton Kaplan, Emily Mendenhall
Social Science & Medicine (2024) Vol. 350, pp. 116901-116901
Closed Access | Times Cited: 3

Emerging trends in management of long COVID with a focus on pulmonary rehabilitation: A review
A. Li, Willis X. Li, Jinghong Li
The Clinical Respiratory Journal (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 3

Challenges and opportunities in long COVID research
Rebecca E. Hamlin, Catherine A. Blish
Immunity (2024) Vol. 57, Iss. 6, pp. 1195-1214
Closed Access | Times Cited: 3

Long COVID as a Disease of Accelerated Biological Aging: An Opportunity to Translate Geroscience Interventions
Areez Shafqat, Mary Clare Masters, Utkarsh Tripathi, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102400-102400
Closed Access | Times Cited: 3

Scroll to top